Patterns of adult psychotherapy in psychiatric practice

Psychiatric Services

Volumn 57, Issue 4, 2006, Pages 472-476

  Wilk, Joshua E ^a   West, Joyce C ^a   Rae, Donald S ^a   Regier, Darrel A ^a  

^a AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DEMOGRAPHY; DEPRESSION; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MENTAL HEALTH SERVICE; OUTCOMES RESEARCH; PSYCHIATRIST; PSYCHOTHERAPY; SCHIZOPHRENIA; UNITED STATES;

EID: 33645661715     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2006.57.4.472     Document Type: Article

References (28)

1. Keller MB, McCullough JP, Klein DN, et al: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 342:1462-1470, 2000
2. Lehman AF, Steinwachs DM: Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin 24:1-10, 1998
3. Barlow DH, Gorman JM, Shear MK, et al: Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 283:2529-2536, 2000.
4. Mavissakalian M: Combined behavioral therapy and pharmacotherapy of agoraphobia. Journal of Pediatric Research 27:179-191, 1993
5. Clarkin JF, Carpenter D, Hull J, et al: Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses. Psychiatric Services 49:531-533, 1998
6. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Ga, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2000
7. Kool S, Dekker J, Duijens IJ, et al: Efficacy of combined therapy and pharmacotherapy for depressed patients with or without personality disorders. Harvard Review of Psychiatry 11:133-141, 2003
8. Lehman AF, Lieberman JA, Dixon LB, et al: Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry 161 (suppl 2):1-56, 2004
9. Olfson M, Marcus S, Pincus H: Trends in office-based psychiatric practice. American Journal of Psychiatry 156:451-457, 1999
10. Olfson M, Marcus S, Druss B: National trends in the outpatient treatment of depression. JAMA 287:203-209, 2002
11. Langer F: Use of anti-depressants is a long-term practice. Apr 10, 2000. Available at http://abenews.go.com/onair/worldnewsto night/poll000410.html
12. Clemens NA, MacKenzie KR, Griffith JL, et al: Psychotherapy by psychiatrists in a managed care environment: must it be an oxymoron? A forum from the APA Commission on Psychotherapy by Psychiatrists: American Psychiatric Association. Journal of Psychotherapy Practice and Research 10:53-62, 2001
13. Regestein QR: Psychiatrists' views of managed care and the future of psychiatry. General Hospital Psychiatry 22:97-106, 2000
14. Guze SB: Psychotherapy and managed care. Archives of General Psychiatry 55:561-562, 1998
15. West JC, Wilk JE, Rae DS, et al: Financial disincentives for the provision of psychotherapy. Psychiatric Service; 54:1582-1583, 2003
16. Pincus HA, Zarin DA, Tanelian TL, et al: Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network. Archives of General Psychiatry 56:441-449, 1999
17. Zarin DA, Pincus HA, Johnson JL, et al: Characterizing psychiatry with findings from the 1996 National Survey of Psychiatric Practice. American Journal of Psychiatry 155:397-404, 1998
18. Shah BV, Barnwell BG, Hunt PN, et al: SUDAAN User's Manual, Release 7.0. Research Triangle Park, NC, Research Triangle Institute, 1996
19. Goldman W, McCulloch J, Cuffel B, et al: Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. Psychiatric Services 49:477-482, 1998
20. Sharfstein SS, Goldman H: Financing the medical management of mental disorders. American Journal of Psychiatry 146:345-349, 1989
21. Wilk JE, Regier DA, West JC, et al: Current status of the psychiatry workforce in the US. Presented at the annual meeting of the American Psychiatric Association, San Francisco, May 17-21, 2003
22. Scully JH, Wilk JE: Selected characteristics and data of psychiatrists in the United States, 2001-2002. Academic Psychiatry 27:247-251, 2003
23. Nikelly AG: Drug advertisements and the medicalization of unipolar depression in women. Health Care for Women International 16:229-242, 1995
24. Goldman R, Montague M: Marketing "mind mechanics": decoding antidepressant drug advertisements. Social Science Medicine 22:1047-1058, 1986.
25. Wilk J, Duffy FF, West JC, et al: Perspectives on the future of the mental health disciplines, in Mental Health, United States, 2002. Edited by Manderscheid RW, Henderson MJ. DHHS pub no SMA-3938. Rockville, Md, Substance Abuse and Mental Health Services Administration, 2004
26. Mark TL, Coffey RM, Vandivort-Warren R, et al: MHSA Spending Estimate Team: US spending for mental health and substance abuse treatment, 1991-2001. Health Affairs, Web exclusive, Mar 29, 2005. Available at http://content. healthaffairs.org/cgi /content/full/hlthaff.w5.l33/dcl
27. Weissman M: Access to evidence-based psychotherapies. Presented at the annual meeting of the American Psychiatric Association, New York, May 1-6, 2004
28. Pingitore DP, Scheffler RM, Sentell T, et al: Comparison of psychiatrists and psychologists in clinical practice. Psychiatric Services 53:977-983, 2002